Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid ...
A UT Southwestern Medical Center quality improvement team led a large-scale, multispecialty project in partnership with the Parkland Center of Innovation and Value to help patients with implantable ...
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...
A creative approach to wearable cardioverter-defibrillators (WCDs)—in the form of a water-resistant patch—appears to be both safe and effective in patients with ventricular arrhythmias that put them ...
The study, published in the New England Journal of Medicine on Nov. 24, studied patient outcomes for three methods of defibrillation: standard defibrillation; double sequential external defibrillation ...
Among patients with refractory ventricular fibrillation (VF), survival to hospital discharge was more frequent with double sequential external defibrillation (DSED) and vector-change (VC) ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent development of the implantable cardioverter-defibrillator (ICD). ICDs are ...
As of January this year, Aotearoa New Zealand became just the second country (after Canada) to adopt a groundbreaking new procedure for patients experiencing cardiac arrest. Known as “double ...
In New Zealand, ambulance crews treat about seven people a day who are in cardiac arrest, meaning their heart is no longer pumping blood to vital organs. Sadly, fewer than one in eight are likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results